background although use induce blood stage malaria infect proven valuable tool test efficacy vaccine drug plasmodium falciparum limit factor avail good manufacture practice gmpcompliant define p strain vivo aim studi develop costeffect method largescal product cell bank suitable clinic trial method geneticallyattenu parasite gap product target delete gene encode knob assoc histidin rich protein sharp strain master bank mcb manufacture culture fda approve single close system sterile plastic bioreactor common use manufacture screen comply standard appropri cryopreserv subject extent ensure amp compliance phase investing product result two under vial success harvest parasitaemia ring confirm release criterion met sterile absence viral contain endotoxin parasite viable follow cryopreserv ident antimalari drug density concur vitro culture use wave achieve conduit provide methodology administer 